Patents by Inventor Sannah Zoffmann

Sannah Zoffmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROARYLMETHYL AMIDES
    Publication number: 20140194436
    Abstract: The present invention relates to compounds of the formula wherein A1, A2, A3 and R1 to R8 are defined in the description, and to pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as particularly dyslipidemia, atherosclerosis and cardiovascular diseases.
    Type: Application
    Filed: February 24, 2014
    Publication date: July 10, 2014
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Paul Hebeisen, Hugues Matile, Stephan Roever, Matthew Wright, Sannah Zoffmann Jensen
  • Heteroarylmethyl amides
    Patent number: 8729105
    Abstract: The present invention relates to compounds of the formula wherein A1, A2, A3 and R1 to R8 are defined in the description, and to pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as particularly dyslipidemia, atherosclerosis and cardiovascular diseases.
    Type: Grant
    Filed: September 7, 2011
    Date of Patent: May 20, 2014
    Assignee: Hoffmann La-Roche Inc.
    Inventors: Paul Hebeisen, Hugues Matile, Stephan Roever, Matthew Wright, Sannah Zoffmann Jensen
  • Tmem27 antibody
    Patent number: 8512704
    Abstract: The present invention relates to an antibody directed to a beta cell marker protein, in particular to an antibody directed to the protein TMEM27.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: August 20, 2013
    Assignee: Genentech, Inc.
    Inventors: Kerstin Jahn-Hofmann, Sannah Zoffmann Jensen, Hugues Matile, Cristiano Migliorini, Haiyan Wang
  • Antibodies directed to mGluR7
    Patent number: 8354102
    Abstract: The present invention provides an antibody directed to an epitope of a G-protein coupled receptor, wherein the antibody binds to the extracellular N-terminal region of the receptor and the binding of the antibody to the G-protein coupled receptor induces receptor internalization in cells.
    Type: Grant
    Filed: May 8, 2008
    Date of Patent: January 15, 2013
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Sannah Zoffmann Jensen, Hugues Matile, Christoph Ullmer
  • BETA CELL MARKER ANTIBODY
    Publication number: 20120134927
    Abstract: The present invention relates to an antibody directed to a beta cell marker protein, in particular to an antibody directed to the protein TMEM27.
    Type: Application
    Filed: July 30, 2010
    Publication date: May 31, 2012
    Applicant: Hoffmann-La Roche, Inc.
    Inventors: Kerstin Jahn-Hofmann, Sannah Zoffmann Jensen, Hugues Matile, Christiano Migliorini, Haiyan Wang
  • HETEROARYLMETHYL AMIDES
    Publication number: 20120065212
    Abstract: The present invention relates to compounds of the formula wherein A1, A2, A3 and R1 to R8 are defined in the description, and to pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as particularly dyslipidemia, atherosclerosis and cardiovascular diseases.
    Type: Application
    Filed: September 7, 2011
    Publication date: March 15, 2012
    Inventors: Paul Hebeisen, Hugues Matile, Stephan Roever, Matthew Wright, Sannah Zoffmann Jensen
  • ANTIBODY DIRECTED TO G PROTEIN COUPLED RECEPTORS (GPCR)
    Publication number: 20100303802
    Abstract: The present invention provides an antibody directed to an epitope of a G-protein coupled receptor, wherein the antibody binds to the extracellular N-terminal region of the receptor and the binding of the antibody to the G-protein coupled receptor induces receptor internalization in cells.
    Type: Application
    Filed: May 8, 2008
    Publication date: December 2, 2010
    Inventors: Sannah Zoffmann Jensen, Hugues Matile, Christoph Ullmer
  • Ligand-receptor tracking assays
    Publication number: 20060105393
    Abstract: The present invention provides an image-based method of screening for compounds based on the measurement of internalization of a fluorescently labeled ligand. It further provides a multiplex method for high content screening of compounds wherein at least two cellular parameters are measured.
    Type: Application
    Filed: October 21, 2005
    Publication date: May 18, 2006
    Inventors: Christian Apfel, Thilo Enderle, Sannah Zoffmann, Mireille Penski
  • Fluorescently labeled growth hormone secretagogue
    Publication number: 20060073522
    Abstract: The present invention relates to a fluorescently labeled growth hormone secretagogue which can be used for the identification of compounds capable of binding to growth hormone secretagogue receptors, in particular by high throughput screening.
    Type: Application
    Filed: December 12, 2005
    Publication date: April 6, 2006
    Inventors: Thilo Enderle, Martin Graf, Cornelia Hertel, Sannah Zoffmann, Eric Kitas
  • Fluorescently labeled growth hormone secretagogue
    Publication number: 20050085421
    Abstract: The present invention relates to a fluorescently labeled growth hormone secretagogue which can be used for the identification of compounds capable of binding to growth hormone secretagogue receptors, in particular by high throughput screening.
    Type: Application
    Filed: October 14, 2004
    Publication date: April 21, 2005
    Inventors: Thilo Enderle, Martin Graf, Cornelia Hertel, Sannah Zoffmann, Eric Kitas